Brady Heads Into Q4 Print After a Rare 20% Earnings Pop
Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BRC reports its fiscal Q4 results today with investors watching to see whether the company can follow one of its largest single-day moves in recent memory.
The clearest precedent is last quarter's print. In May, Brady jumped more than 20% in a single session and sustained nearly 24% over the following five days — an unusually strong post-earnings reaction for an industrial company of its profile. That move has set expectations high. The stock is now up roughly 15% year-to-date, though it has retraced nearly 6% over the past month and shed another 3.3% in the past week, closing at $90.34. Options positioning is broadly neutral heading in: the put/call ratio is running at 0.94, barely above its 20-day average of 0.88, with a z-score near zero. Neither bulls nor bears are pressing hard in the derivatives market ahead of the release.
Short interest is essentially a non-story here. Bears hold just 1.5% of the free float — a low conviction position — and that share has been drifting lower for a month, down roughly 3% over both the past week and the past month. Borrow availability is extraordinarily loose, with nearly 8,300% of short interest available to lend. Cost to borrow remains negligible at around 0.5%, up modestly on the week but well within a normal range. There is no squeeze dynamic, no borrow stress, and no sign that short sellers have a high-conviction view on the downside.
The more interesting context is insider activity. On September 1 — three days before today's print — multiple executives received equity grants and simultaneously sold shares to cover tax obligations, a routine compensation-related pattern rather than a discretionary view signal. The CFO, COO, General Counsel, and President of Americas & Asia all filed transactions of the type F (tax withholding), with no open-market purchases or sales on record. None of these are conviction trades. FMR LLC remains the largest disclosed institutional holder at roughly 15% of shares, having grown its stake from 13.7%, while Neuberger Berman trimmed its position from 5.5% to 4.5% — a modest reduction that brought it below the 5% disclosure threshold.
On the analyst side, only one recent action carries weight: Sidoti & Co. upgraded Brady to Buy in June with a $103 target. The consensus mean price target is $110, implying roughly 22% upside from the current price — a reasonably constructive Street view, though the most recent bellwether-firm rating data in the snapshot dates to early 2024 and should be treated with caution. Brady's dividend score ranks in the 95th percentile, reflecting its long-running shareholder return commitment, and its ORTEX short score of 30.8 is low and stable, suggesting no escalation in bearish signals.
The print will test whether Brady's May surprise was a one-off or the start of a durable re-rating — and whether management's guidance supports the $110 consensus target that the Street is currently anchored to.
Stocks in this article
See the live data behind this article on ORTEX.
Open BRC on ORTEX →How this article was generated
- Generated
- 4 Sept 2026, 04:00
- Data as of
- 4 Sept 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.